424 related articles for article (PubMed ID: 33013877)
1. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
Front Immunol; 2020; 11():2071. PubMed ID: 33013877
[TBL] [Abstract][Full Text] [Related]
2. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen.
Horai R; Silver PB; Chen J; Agarwal RK; Chong WP; Jittayasothorn Y; Mattapallil MJ; Nguyen S; Natarajan K; Villasmil R; Wang P; Karabekian Z; Lytton SD; Chan CC; Caspi RR
J Autoimmun; 2013 Aug; 44():21-33. PubMed ID: 23810578
[TBL] [Abstract][Full Text] [Related]
3. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
4. Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis.
Silver PB; Horai R; Chen J; Jittayasothorn Y; Chan CC; Villasmil R; Kesen MR; Caspi RR
J Immunol; 2015 Apr; 194(7):3011-9. PubMed ID: 25716996
[TBL] [Abstract][Full Text] [Related]
5. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis.
Keino H; Takeuchi M; Usui Y; Hattori T; Yamakawa N; Kezuka T; Sakai JI; Usui M
Br J Ophthalmol; 2007 Jan; 91(1):105-10. PubMed ID: 16943228
[TBL] [Abstract][Full Text] [Related]
6. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
[TBL] [Abstract][Full Text] [Related]
8. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells.
Silver PB; Agarwal RK; Su SB; Suffia I; Grajewski RS; Luger D; Chan CC; Mahdi RM; Nickerson JM; Caspi RR
J Immunol; 2007 Oct; 179(8):5146-58. PubMed ID: 17911600
[TBL] [Abstract][Full Text] [Related]
9. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
[TBL] [Abstract][Full Text] [Related]
10. Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen.
Lee DJ; Taylor AW
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8862-7. PubMed ID: 21989727
[TBL] [Abstract][Full Text] [Related]
11. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
12. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
13. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity.
Grajewski RS; Silver PB; Agarwal RK; Su SB; Chan CC; Liou GI; Caspi RR
J Exp Med; 2006 Apr; 203(4):851-6. PubMed ID: 16585264
[TBL] [Abstract][Full Text] [Related]
14. Partial retinal photoreceptor loss in a transgenic mouse model associated with reduced levels of interphotoreceptor retinol binding protein (IRBP, RBP3).
Liu YH; Corbett C; Klaska IP; Makinen K; Nickerson JM; Cornall RJ; Kuffova L; Forrester JV
Exp Eye Res; 2018 Jul; 172():54-65. PubMed ID: 29571629
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.
Agarwal RK; Horai R; Viley AM; Silver PB; Grajewski RS; Su SB; Yazdani AT; Zhu W; Kronenberg M; Murray PJ; Rutschman RL; Chan CC; Caspi RR
J Immunol; 2008 Apr; 180(8):5423-9. PubMed ID: 18390724
[TBL] [Abstract][Full Text] [Related]
16. Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.
Lee DJ; Taylor AW
J Immunol; 2013 Oct; 191(8):4103-11. PubMed ID: 24043903
[TBL] [Abstract][Full Text] [Related]
17. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis.
Hara Y; Caspi RR; Wiggert B; Chan CC; Streilein JW
Curr Eye Res; 1992; 11 Suppl():97-100. PubMed ID: 1424755
[TBL] [Abstract][Full Text] [Related]
18. Increased Regulatory T Cells in Spleen during Experimental Autoimmune Uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Lin X; Kijlstra A
Ocul Immunol Inflamm; 2010 Jan; 18(1):38-43. PubMed ID: 20128648
[TBL] [Abstract][Full Text] [Related]
19. Colitis in a transgenic mouse model of autoimmune uveitis may be induced by neoantigen presentation in the bowel.
Mölzer C; Liu YH; Muckersie E; Klaska IP; Cornall R; Wilson HM; Kuffová L; Forrester JV
Sci Rep; 2023 Jan; 13(1):1256. PubMed ID: 36690619
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions.
Sugita S; Horie S; Nakamura O; Maruyama K; Takase H; Usui Y; Takeuchi M; Ishidoh K; Koike M; Uchiyama Y; Peters C; Yamamoto Y; Mochizuki M
J Immunol; 2009 Oct; 183(8):5013-22. PubMed ID: 19801522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
